Health Care: Drugs

Pacira Pharmaceuticals Inc (PCRX: NASDAQ)

$33.35 n/a | n/a%
12/09/16 - 04:00 PM ET
Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 249.00M 197.67M 85.55M 39.08M
Cost of Sales 55.78M 62.78M 44.61M 25.90M
Gross Operating Profit 193.22M 134.89M 40.94M 13.19M
Selling, General, and Administrative Expenses 139.04M 106.66M 62.51M 46.31M
Research & Development 28.66M 18.73M 21.56M 9.94M
Operating Income before D & A (EBITDA) 25.51M 9.50M -43.12M -43.06M
Depreciation & Amortization 16.06M 14.66M 10.16M 6.24M
Interest Income 678.00K 382.00K 259.00K 275.00K
Other Income - Net -5.00M -5.24M -8.62M -1.45M
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) 5.13M -10.02M -61.65M -50.47M
Interest Expense 3.01M 3.52M 2.70M 1.81M
Pre-Tax Income 2.12M -13.54M -64.35M -52.28M
Income Taxes 264.00K 173.00K -442.00K 0.00
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations 1.86M -13.72M -63.91M -52.28M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations 1.86M -13.72M -63.91M -52.28M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income 1.86M -13.72M -63.91M -52.28M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
1.86M -13.72M -63.91M -52.28M
Preferred Dividends
Net Income Available To Common 1.86M -13.72M -63.91M -52.28M
Basic EPS from Continuing Ops. 0.05 -0.39 -1.93 -1.72
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations 0.05 -0.39 -1.93 -1.72
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total 0.05 -0.39 -1.93 -1.72
Basic Normalized Net Income/Share 0.05 -0.39 -1.93 -1.72
EPS fr Continuing Ops. 0.04 -0.39 -1.93 -1.72
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. 0.04 -0.39 -1.93 -1.72
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total 0.04 -0.39 -1.93 -1.72
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
0.04 -0.39 -1.93 -1.72
Dividends Paid per Share 0.00 0.00 0.00 0.00

Portfolios with PCRX

Latest PCRX Headlines from TheStreet

More Financial News for PCRX

Press Releases for PCRX

See All Press Releases
brokerage partners
connect with Stockpickr
Fan us on FaceBook
Follow us on Twitter